Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
This study is currently recruiting participants.
Study NCT00530244   Information provided by University of Massachusetts
First Received: September 13, 2007   Last Updated: December 4, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cystic Fibrosis
Additional conditions recognized in this trial
Fibrosis
More general conditions related to this trial
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Lung Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
Docosahexaenoic acid (DHA)
Standard formula (Enfamil)
Sponsors listed in this trial
University of Massachusetts
Cystic Fibrosis Foundation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services